Table 3.
PIV3 | RSV | hMPV | hBoV | Ad | |
---|---|---|---|---|---|
Total number of detections | 41 | 52 | 68 | 64 | 86 |
No. of single detections (% of total) | 15 (36.6) | 26 (50) | 37 (54.4) | 12 (18.8) | 24 (27.9) |
Duration of hospitalization, median no. of days | 8 | 9 | 7 | 7.5 | 7.5 |
Dual detection with rhinovirus: No. (%) | 6 (14.6) | 10 (19.2) | 7 (10.3) | 8 (12.5) | 18 (20.9) |
Duration of hospitalization, median no. of days | 12 | 8 | 7 | 7.5 | 9 |
asymptotic significance (2-tailed) | 0.030* | 0.886 | 0.742 | 0.907 | 0.099 |
Dual detection with other respi. Virus: No. (%) | 11 (26.8) | 9 (17.3) | 8 (11.8) | 21 (32.8) | 19 (22.1) |
Duration of hospitalization, median no. of days | 8 | 9 | 10 | 9 | 9 |
asymptotic significance (2-tailed) | 0.213 | 0.338 | 0.009* | 0.384 | 0.094 |
Dual detection with rhinovirus vs. dual detection with other respiratory virus | 0.245 | 0.432 | 0.144 | 0.431 | 0.939 |
Asymptotic significance (2-tailed) |
Mann–Whitney U test.
p < 0.05. No other significant between-group differences.